Dr. Latib is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
122 Maple Avenue
7th Floor
White Plains, NY 10601Phone+1 914-849-4200Fax+1 914-849-5431
Summary
- Dr Azeem Latib is the Section Head and Director of Interventional Cardiology and Director of Structural Heart Interventions at Montefiore Medical Center in New York and has been in practice 26 years. He started his career in South Africa and obtained his specialization in internal medicine and cardiology at Groote Schuur Hospital in the University of Cape Town. Thereafter, he trained in interventional cardiology at San Raffaele Hospital in Milan, where he worked with Antonio Colombo as a senior interventional cardiologist at San Raffaele Hospital and EMO-GVM Centro Cuore Columbus He has published over 700 manuscripts in peer-reviewed journals and numerous book chapters. His interests and experience lie in complex coronary interventions, structural heart disease and new device innovation. He is the principal investigator in numerous First-in-Human, Early Feasibility Studies, CE-mark, FDA-approved IDE and international multi-centre studies both in coronary and structural interventions. Dr Latib is a leading expert in complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions.
Dr. Latib specializes in adult congenital heart disease, interventional cardiology, and peripheral endovascular interventional cardiology.
The Montefiore Structural Heart Program has become a world-renowned prrogram offering cuttting-edge and innovative transcatheter therapies for valvular disease.
Education & Training
- University of the WitwatersrandClass of 1995
Certifications & Licensure
- NY State Medical License 2018 - 2025
Clinical Trials
- The Bronx-Valve Registry Start of enrollment: 2022 Apr 01
- European Study Evaluating the EMBLOK Embolic Protection System During TAVR Start of enrollment: 2017 Mar 08
- Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Start of enrollment: 2021 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsOutcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis.Florian Schlotter, Mizuki Miura, Karl-Patrik Kresoja, Brunilda Alushi, Hannes Alessandrini
Eurointervention. 2021-07-20 - 22 citationsTranscatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization.Tian-Yuan Xiong, Walid Ben Ali, Yuan Feng, Kentaro Hayashida, Hasan Jilaihawi
Nature Reviews. Cardiology. 2023-01-01 - 19 citationsUse of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).Giulio Falasconi, Francesco Melillo, Luigi Pannone, Marianna Adamo, Federico Ronco
Catheterization and Cardiovascular Interventions. 2021-04-02
Lectures
- Debate: Surgical Tricuspid Intervention Not for Everyone!2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Right Sided Valve Disease Interventions2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Transcatheter Mitral and Tricuspid Valve Interventions: Imaging Determines Success2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: